StatPearls, LLC

  • Analgesics, Opioid
  • Anesthesia, Epidural
  • Anesthesia, General
  • Liposomes
  • Morphine

Epidural Morphine

Epidural morphine is a medication used for analgesia, whether as an adjunct to general anesthesia or as the sole technique for surgical anesthesia. This medication is the first opioid approved for neuraxial administration by the U.S. Food and Drug Administration (FDA). Epidural morphine has been the most widely utilized opioid in clinical practice when administered via this route. In 2004, liposome-based extended-release epidural morphine (EREM) also received FDA approval. This activity describes the indications, action, and contraindications for epidural morphine as a valuable agent for treating acute and chronic moderate-to-severe pain. Furthermore, this activity will highlight the mechanism of action, adverse event profile, and other crucial factors, such as dosing, pharmacokinetics, monitoring, contraindications, and toxicity, pertinent for interprofessional team members in managing epidural morphine in patients receiving the medication.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABOS — Accredited CMEUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 6 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left